<DOC>
	<DOCNO>NCT01479686</DOCNO>
	<brief_summary>Many clinical study report iMRI , however , evidence level relatively good people hope . Based available literature , , best , level 2 evidence iMRI-guided surgery effective conventional neuronavigation-guided surgery . The investigator aim single center prospective randomize triple-blind control clinical trial ass effect 3.0T high-field intraoperative MRI-guided glioma resection surgical efficiency progression-free survival malignant glioma provide level 2A evidence clinical application .</brief_summary>
	<brief_title>iMRI Guided Resection Cerebral Glioma Surgery</brief_title>
	<detailed_description>Since first introduction GE Signa System Brigham Women 's Hospital world 's first intraoperative MRI 1993 , iMRI increasingly apply one important technique concept field neurosurgery . Many clinical study report respect , however , evidence level relatively good people hope be.Based available literature , , best , level 2B evidence iMRI-guided surgery effective conventional neuronavigation-guided surgery . Rationale : Intraoperative magnetic resonance imaging ( MRI ) -guided intracranial surgery , one whose frequently report indication cerebral glioma surgery , may help update image navigational system , provide data extent resection localization tumor remnant , thereby enable intraoperative reliable immediate resection control eliminate effect brain shift extent resection . Intraoperative MRI system divide low-field intraoperative MRI ( 0.5T less ) high-field intraoperative MRI ( 1.5T ) accord various field strength . The latter enables intraoperative image high quality available image modality cost equipment requirement . Purpose : We aim single center prospective randomize triple-blind control clinical trial ass effect 3.0T high-field intraoperative MRI-guided glioma resection surgical efficiency progression-free survival malignant glioma . We hypothesize use high-field intraoperative MRI enable complete tumor resection conventional neuronavigation-guided resection , reduce morbidity lead improved progression-free survival quality life patient malignant glioma .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<criteria>1 . Individuals age 1870 year highly suspect ( assess study surgeon ) , newly diagnose , untreated malignant glioma ( see appendix 1 ) 2 . Individuals supratentorial glioma body involve frontal lobe , temporal lobe , parietal lobe , occipital lobe insular lobe 3 . Individuals preoperative assessment radiological radicality achieve 4 . Individuals either without tumor eloquent area ( see appendix 2 ) 5 . Karnofsky performance scale 70 6 . All patient give write informed consent . Appendix 1 . Histological types（WHO 2007） : 1 . Astrocytic tumour : Pilomyxoid astrocytoma 9425/3 Pleomorphic xanthoastrocytoma 9424/3 Diffuse astrocytoma 9400/3 Fibrillary astrocytoma 9420/3 Gemistocytic astrocytoma 9411/3 Protoplasmic astrocytoma 9410/3 Anaplastic astrocytoma 9401/3 Glioblastoma 9440/3 Giant cell glioblastoma 9441/3 Gliosarcoma 9442/3 2 . Oligodendroglial tumour : Oligodendroglioma 9450/3 Anaplastic oligodendroglioma 9451/3 3 . Oligoastrocytic tumour : Oligoastrocytoma 9382/3 Anaplastic oligoastrocytoma 9382/3 4 . Ependymal tumour : Ependymoma 9391/3 Cellular 9391/3 Papillary 9393/3 Clear cell 9391/3 Tanycytic 9391/3 Anaplastic ependymoma 9392/3 Morphology code International Classification Diseases Oncology ( ICDO ) { 614A } Systematized Nomenclature Medicine ( http : //snomen.org ) . Behaviour cod /0 benign tumour , /3 malignant tumour /1 borderline uncertain behaviour . Tumor grade : grade II~IV accord late WHO grade criterion ; Appendix 2 . Tumor location eloquent area : locate close area dominanthemisphere associate motor language function , include : 1 . Frontal lobe , divide inferior frontal gyrus ( BA44Pars opercularis , BA45Pars triangularis/Broca 's area ) , middle frontal gyrus ( BA9 , BA46 ) , superior frontal gyrus ( BA4 , BA6 , BA8 ) , primary motor cortex ( BA4 ) , premotor cortex ( BA6 ) , supplementary motor area ( BA6 ) 2 . Parietal lobe , divide inferior parietal lobule ( BA40supramarginal gyrus , BA39angular gyrus ) , parietal operculum ( BA43 ) , primary somatosensory cortex ( BA1 , BA2 , BA3 ) 3 . Temporal lobe , divide transverse temporal gyrus ( BA41 , BA42 ) , superior temporal gyrus ( BA38 , BA22/Wernicke 's area ) , middle temporal gyrus ( BA21 ) 4 . Insular lobe . 1 . Individuals age &lt; 18 year &gt; 70 year 2 . Tumours midline , basal ganglion , cerebellum , brain stem 3 . Recurrent glioma surgery ( except needle biopsy ) 4 . Primary gliomas history radiotherapy chemotherapy 5 . Contraindications preclude intraoperative MRIguided surgery 6 . Inability give inform consent 7 . KPS &lt; 70 8 . Renal insufficiency hepatic insufficiency 9 . History malignant tumour body site 10 . Tumour location ( important eloquent area ) enable complete resection tumour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>GLIOMA</keyword>
	<keyword>NEURONAVIGATION</keyword>
	<keyword>INTERVENTIONAL MRI</keyword>
</DOC>